Lipoprotein (a) and Cardiovascular Diseases―Revisited―
AY Jang, SH Han, IS Sohn, PC Oh, KK Koh - Circulation Journal, 2020 - jstage.jst.go.jp
Two decades ago, it was recognized that lipoprotein (a)(Lp (a)) concentrations were
elevated in patients with cardiovascular disease (CVD). However, the importance of Lp (a) …
elevated in patients with cardiovascular disease (CVD). However, the importance of Lp (a) …
Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies
A Cesaro, A Schiavo, E Moscarella… - Journal of …, 2021 - journals.lww.com
Abstract Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing
evidence indicates its causal association with atherosclerotic disease because of the …
evidence indicates its causal association with atherosclerotic disease because of the …
Lipoprotein (a) and its significance in cardiovascular disease: a review
FD Lau, RP Giugliano - JAMA cardiology, 2022 - jamanetwork.com
Importance Lipoprotein (a)(Lp [a]) is a low-density lipoprotein (LDL) cholesterol–like particle
bound to apolipoprotein (a). This novel marker of cardiovascular disease acts through …
bound to apolipoprotein (a). This novel marker of cardiovascular disease acts through …
Lipoprotein (a) in atherosclerotic diseases: from pathophysiology to diagnosis and treatment
Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …
Lipoprotein (a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
A Rehberger Likozar, M Zavrtanik… - Annals of medicine, 2020 - Taylor & Francis
Abstract Lipoprotein (a)(Lp (a)) was discovered more than 50 years ago, and a decade later,
it was recognized as a risk factor for coronary artery disease. However, it has gained …
it was recognized as a risk factor for coronary artery disease. However, it has gained …
Lipoprotein (a) as a cardiovascular risk factor: current status
BG Nordestgaard, MJ Chapman, K Ray… - European heart …, 2010 - academic.oup.com
Aims The aims of the study were, first, to critically evaluate lipoprotein (a)[Lp (a)] as a
cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp (a), on …
cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp (a), on …
Lipoprotein (a)-link between atherogenesis and thrombosis
Lipoprotein (a)-Lp (a)-is an independent risk factor for cardiovascular disease (CVD).
Indeed, individuals with plasma concentrations of Lp (a)> 200 mg/l carry an increased risk of …
Indeed, individuals with plasma concentrations of Lp (a)> 200 mg/l carry an increased risk of …
Lipoprotein (a): when to measure and how to treat?
D Rhainds, MR Brodeur, JC Tardif - Current Atherosclerosis Reports, 2021 - Springer
Abstract Purpose of Review The purpose of this article is to review current evidence for
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …
lipoprotein (a)(Lp (a)) as a risk factor for multiple cardiovascular (CV) disease phenotypes …
Lipoprotein (a): more interesting than ever after 50 years
Despite the wealth of epidemiologic evidence supporting Lp (a) concentration as a CHD risk
factor, the lack of a definitive functional mechanism involving an Lp (a)-dependent pathway …
factor, the lack of a definitive functional mechanism involving an Lp (a)-dependent pathway …
Lipoprotein (a)—the crossroads of atherosclerosis, atherothrombosis and inflammation
S Ugovšek, M Šebeštjen - Biomolecules, 2021 - mdpi.com
Increased lipoprotein (a)(Lp (a)) levels are an independent predictor of coronary artery
disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD …
disease (CAD), degenerative aortic stenosis (DAS), and heart failure independent of CAD …